Role of Lymphadenectomy in the Surgical Treatment of Clinical Localized Prostate Cancer

Posted by Mohamad E. Allaf, MD | Aug 2024

Mohamad E. Allaf, MD, presented “Role of Lymphadenectomy in the Surgical Treatment of Clinical Localized Prostate Cancer” during the 43rd Annual Ralph E. Hopkins Urology Seminar on January 31, 2024, in Jackson Hole, Wyoming.

This content is available free to the GRU Community. Login or create an account to view it.

Create an Account

How to cite: Allaf, Mohamad E. “Role of Lymphadenectomy in the Surgical Treatment of Clinical Localized Prostate Cancer.” January 31, 2024. Accessed Dec 2024. https://grandroundsinurology.com/role-of-lymphadenectomy-in-the-surgical-treatment-of-clinical-localized-prostate-cancer/

Role of Lymphadenectomy in the Surgical Treatment of Clinical Localized Prostate Cancer – Summary

Mohamad E. Allaf, MD, discusses the use cases for lymphadenectomy in the surgical treatment of clinically localized prostate cancer. Dr. Allaf begins by addressing the rationale for performing lymphadenectomy, emphasizing its diagnostic and therapeutic potential in prostate cancer management.

A central focus of the presentation is the debate surrounding lymphadenectomy and its implications for patient outcomes. Dr. Allaf reviews the current evidence, highlighting studies that suggest extended lymphadenectomy may provide superior oncologic control by increasing the likelihood of detecting metastatic nodes in high- and intermediate-risk patients. Dr. Allaf also delves into the nuances of patient selection and determining when and how to integrate lymphadenectomy into the surgical treatment of prostate cancer.

About The 43rd Annual Ralph E. Hopkins Urology Seminar:

The Ralph E. Hopkins Urology Seminar is a multi-day meeting focused on training urologists in the latest in assessing, diagnosing, and treating urologic conditions in the clinical setting. Updates are provided on urologic cancers, stone disease, urologic reconstruction, female urology, infertility, sexual function, emerging surgical techniques, and general urology. The 43rd iteration of the meeting took place from January 31st to February 2nd, 2024, in Jackson Hole, Wyoming.

For further educational activities from this conference, visit our collection page.

About The Author

Mohamad E. Allaf, MD

Mohamad E. Allaf, MD, is Professor of Urology and Oncology, as well as Director of the Department of Urology and the Brady Urological Institute, Urologist-in-Chief of the Johns Hopkins Hospital, and Director of Minimally Invasive and Robotic Surgery. Dr. Allaf earned his medical degree from Johns Hopkins University, where he also completed his residency in urology. Dr. Allaf is a world renowned surgeon-scientist who has performed more than 2,000 robotic procedures and published over 250 peer reviewed research papers in the field's best journals. Dr. Allaf has used Dr. Patrick Walsh's method of radical prostatectomy as the basis for his own anatomic method to this complex operation. Dr. Allaf is also amongst the leaders in kidney cancer surgery, having served on the American Urological Association (AUA) Guideline Committee for Kidney Cancer. He led a team who performed the rigorous analysis to help inform the most recent guidelines that was funded by the Agency for Healthcare Research and Quality (AHRQ). He is best known for his ability to save the kidney and remove the tumor in patients with kidney tumors. Dr. Allaf runs a research endeavor aiming to decrease the morbidity associated with the treatment of cancer, and he has mentored numerous leaders in academic urology. He is actively involved in fundraising for research and education, and believes in expanding the base of support in order to advance this important mission.

Join the GRU Community

- Why Join? -

Share This

Chat with usLiveChat